Retour aux projets

16640.1 PFLS-LS

16640.1 PFLS-LS

Résumé

Identification and characterization of specific venom-derived peptides inhibiting the Tumour Necrosis Factor receptor 1: development of novel anti-inflammatory drug candidates

Textes supplémentaires

Abstract

Our objective is the discovery of venom peptides selectively inhibiting the binding of Tumor Necrosis Factor (TNF) to TNF receptor 1 (TNFR1) as anti-inflammatory drug candidates. Active venom extracts identified after screening of a library using a novel assay will be submitted to deconvolution. After purification, structural elucidation and synthesis of the best candidates, the most promising molecules will be characterized and their druggability potential will be assessed.

Participants

Vincent Mutel

Wirtschaftspartner

vincent.mutel@inflamalps.com

INFLAMALPS SA CHE-477.522.287 Vincent Mutel Route de l'Ile-au-Bois 1A 1870 Monthey VS CH

Gerardo Turcatti

Kontaktperson

gerardo.turcatti@epfl.ch

EPFL LCC BSF Gerardo Turcatti Station 15 1015 Lausanne VD CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2014-10-31
Date de fin
2016-01-31
Coûts totaux approuvés
CHF 186610.00
Section
20 Förderbereich Life Sciences
Domaine politique NABS
Industrielle Produktivität und Technologie

Disciplines de recherche

  • T490 Biotechnology 100.0%